While lipid nanoparticles are the most clinically advanced drug delivery system for nucleic acid therapeutics, they are only one tool in a toolbox of potential delivery vehicles.

In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss additional tools, including polymeric nanoparticles, protein-based nanoparticles and extracellular vesicles with a focus on:

• Where LNPs potentially fall short
• Where different tools can enable therapeutic delivery
• Challenges to achieving meaningful clinical impact for these different vehicles
• Building out a portfolio of delivery vehicles

To learn more about the PODD Conference, please visit Drug-Delivery.org.